The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.
By Gina Kolata Like an estimated three million Americans, Nancy Guthrie, the 84-year-old mother of the NBC News anchor Savannah Guthrie, has a pacemaker implanted in her chest. Law enforcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results